Angiogenesis: new opportunities and solutions for drug development. Predictive markers for antiangiogenic drugs.
Gerber
Hans-Peter
HP
Department of Molecular Oncology, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D011237:Predictive Value of Tests
D020533:Angiogenesis Inhibitors; D015415:Biomarkers